Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
AstraZeneca
AstraZeneca
Amager Hospital
University Health Network, Toronto
Virginia Commonwealth University
Brigham and Women's Hospital
Washington University School of Medicine
Karolinska Institutet
Duke University
NHS Greater Glasgow and Clyde
Brigham and Women's Hospital
M.D. Anderson Cancer Center
University of Alberta
M.D. Anderson Cancer Center
Stichting Hemato-Oncologie voor Volwassenen Nederland
University Health Network, Toronto
University Health Network, Toronto
University Medical Centre Ljubljana
Abramson Cancer Center at Penn Medicine
University of Southern California
Guangdong Provincial People's Hospital
University of Washington
University of Stavanger
West Virginia School of Osteopathic Medicine
Abramson Cancer Center at Penn Medicine
Universitätsklinikum Hamburg-Eppendorf
University of Washington
University Hospital Muenster
Medical University of Silesia
Massachusetts General Hospital
Women's College Hospital
University of Waterloo
Population Health Research Institute
University of Washington
Silesian Centre for Heart Diseases
University Hospital, Akershus
University of Washington
University of Alberta
University of Alberta
VA Office of Research and Development
National Heart Centre Singapore
4th Military Clinical Hospital with Polyclinic, Poland
The Third People's Hospital of Chengdu
Duke University
University of Waterloo
Parc de Salut Mar
University of California, San Diego
Olawuyi Racett Nigeria Ltd
Milton S. Hershey Medical Center
University College, London
Monyan Pharmaceutical (Shanghai) Co., Ltd.